William D. Turner

Corporate Officer/Principal at VERA THERAPEUTICS, INC.

58 year

Health Technology

Consumer Services

William D. Turner active positions

Companies	Position	Start	End
VERA THERAPEUTICS, INC.	Corporate Officer/Principal	2023-01-07	-

Career history of William D. Turner

Former positions of William D. Turner

Companies	Position	Start	End
SIERRA ONCOLOGY, INC.	Chief Tech/Sci/R&D Officer	2020-08-03	2022-06-30
AIMMUNE THERAPEUTICS, INC.	Corporate Officer/Principal	2018-06-30	2020-03-31
Medimmune, Inc.	General Counsel	-	-
MedImmune Vaccines, Inc. MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA	General Counsel	-	-
DYNAVAX TECHNOLOGIES CORPORATION	General Counsel	2006-07-31	-

Training of William D. Turner

The California State University

Undergraduate Degree

Statistics

International

United States

Operational

General Counsel	3
Corporate Officer/Principal	2
Undergraduate Degree	1

Sectoral

Health Technology	7
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	2
DYNAVAX TECHNOLOGIES CORPORATION	Health Technology
VERA THERAPEUTICS, INC.	Health Technology

Private companies	4
MedImmune Vaccines, Inc. MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA	Health Technology
Sierra Oncology, Inc. Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA.	Health Technology
Aimmune Therapeutics, Inc. Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.	Health Technology
Medimmune, Inc.	Health Technology

See company connections